Letter by Bhindi and Ormerod regarding article, "Aortic arch plaques and risk of recurrent stroke and death".
Bhindi
Ravinay
R
Ormerod
Oliver J
OJ
D000925:Anticoagulants; D001018:Aortic Diseases / Q000150:complications; D001241:Aspirin / Q000627:therapeutic use; D050197:Atherosclerosis / Q000150:complications; D005343:Fibrinolytic Agents; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D012306:Risk; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014859:Warfarin; D001241:Aspirin